Novartis in the News

Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment

World Hypertension Day: 17 May 2009

Novartis named one of the "World's most ethical companies" for the third consecutive year